TISOTUMAB VEDOTIN YIELDS RESPONSES AS SECOND-LINE CERVICAL CANCER THERAPY

[Anonymous]

CANCER DISCOVERY, 2021; 11 (6): 1319

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索